KYMR
Kymera Therapeutics, Inc.
Stock
$107.39−2.73 (−2.48%)Close Oct 2, 2026
- Research and development, 2025
- $317M
- YoY, 2025
- +31.8%
- 5-year CAGR
- +38.5%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $317M | +31.8% |
| 2024 | $240M | +27.1% |
| 2023 | $189M | +15.1% |
| 2022 | $164M | +19.9% |
| 2021 | $137M | +120.6% |
| 2020 | $62M | +67.1% |
| 2019 | $37M | — |